News Chart Regeneron Pharmaceuticals, Inc.

Stocks

REGN

US75886F1075

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 01:30:00 16/07/2026 am IST			5-day change	1st Jan Change
664.45 ^USD	+1.27%		+0.24%	-13.92%

15/07	Alnylam Initiates Mid-Stage Study of Mivelsiran in Down Syndrome-Associated Alzheimer's	MT
09/07	Piper Sandler Adjusts Price Target on Regeneron Pharmaceuticals to $854 From $855	MT

8e51b6d76894bdd72f4.UseTuiNOsMCmxfYMVY6A5V7J7YiQN2Jn8uG5m9tpWZA.FaXQ-2s_9qTAn5g-Ae2y1BW7ovzacwMforiL2oMLKekd98nqECfpj8OKrw~5b309ed9eb32557487abbf22809f63ac